Clinical trials
Not yet recruiting Phase 1/2 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 7 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 2 |
| Anna Arthur, PhD | 1 |
| BeOne Medicines | 1 |
| CHU de Quebec-Universite Laval | 1 |
| CSPC Megalith Biopharmaceutical Co.,Ltd. | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| CoRegen, Inc. | 1 |
| D'Or Institute for Research and Education | 1 |
| Dartsbio Pharmaceuticals Ltd. | 1 |
| Genfleet Therapeutics (Shanghai) Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 22 |
| Recurrence | 4 |
| Colorectal Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Melanoma | 2 |
| Multiple Myeloma | 2 |
| Blood Protein Disorders | 1 |
| Burkitt Lymphoma | 1 |
| Cachexia | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.